Mount Sinai Researchers Identify Recessive ReNU2 Syndrome: The Most Prevalent Recessive Neurodevelopmental Disorder to Date

Researchers discover recessive ReNU2 syndrome, the most prevalent recessive neurodevelopmental disorder ever found, offering hope for gene therapy.

By: AXL Media

Published: Mar 30, 2026, 6:32 AM EDT

Source: Information for this report was sourced from the Icahn School of Medicine at Mount Sinai.

A Major Breakthrough in Genomic Medicine

In a landmark study published on March 30, 2026, in Nature Genetics, an international research coalition led by Mount Sinai has described what appears to be the most common recessive neurodevelopmental disorder (NDD) ever identified. The condition, now termed recessive ReNU2 syndrome, is caused by biallelic variants in the RNU2-2 gene. Unlike most well-known genetic disorders that affect protein production, this condition stems from the near-complete absence of U2-2 RNA, a small non-coding molecule essential for brain development.

The Mechanics of Recessive Inheritance

Recessive ReNU2 syndrome follows a classic recessive inheritance pattern, where a child typically inherits one altered copy of the RNU2-2 gene from each parent. While the parents are "carriers" and remain entirely unaffected, the combined deficiency in the child leads to disrupted neurological maturation. The researchers utilized a massive dataset of over 41,000 non-coding genes from the UK’s National Genomics Research Library to pinpoint these variants, comparing the genetic makeup of nearly 15,000 individuals with NDDs against over 52,000 healthy controls.

Clinical Presentation and Symptoms

The symptoms of the disorder are highly variable, reflecting the complex role that U2-2 RNA plays in the developing brain. Common clinical features identified by the research team include: